HTATIP2 and non-small cell lung carcinoma: The results revealed that the NSCLC patients with higher TIP30 mRNA expression showed worse overall survival than those with lower TIP30 mRNA expression (HR = 1.13, 95% CI = 1.10–1.33, P < 0.0001, I2 = 8%) (Figure 1b).